bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.
about
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyInhibitory activity of apogossypol in human prostate cancer in vitro and in vivoHonokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis inductionRemote effect of kidney ischemia-reperfusion injury on pancreas: role of oxidative stress and mitochondrial apoptosisPreoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.Significance of increased apoptosis and Bax expression in human small intestinal adenocarcinoma.Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-κB-dependent gene expression in vivo.Up-regulation of Bcl-2 expression in cultured human lymphocytes after exposure to low doses of gamma radiationLow Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation.Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?Olfactory Performance as an Indicator for Protective Treatment Effects in an Animal Model of Neurodegeneration
P2860
Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422Q35387996-5778BB7B-57FA-42E6-A1A9-093F5A84266EQ35969702-3DBB7E43-1E49-44E3-B7DD-368D18F1A0DBQ36845257-97E114D0-D099-45FB-B5D8-35DDB5FD4C88Q37321935-A956FE4F-E5C5-48D6-8437-79B4ABBA4525Q37389895-E6F835E2-598A-48D0-9080-16B2020371C5Q37422973-8192007D-C2D6-4CC2-844D-953DA39E36B6Q38761728-38FA6EC6-9BBA-4D50-A71C-912B2FA0B5A5Q41832270-8356C1D7-528E-41B7-9267-33DEA63ECEBFQ42669180-4B17A365-2846-4982-B068-8BD55472150CQ53702234-87881E7A-69F1-4A91-BC83-1EFA37EED369Q58781637-C62EA377-0E67-42EC-96C6-D245AE9894C8
P2860
bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@en
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@nl
type
label
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@en
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@nl
prefLabel
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@en
bcl-2/bax ratio as a predictiv ...... n patients with rectal cancer.
@nl
P2093
P1476
bcl-2/bax ratio as a predictiv ...... in patients with rectal cancer
@en
P2093
A C Tsamandas
C Vagianos
D Kardamakis
H P Kalofonos
T G Kourelis
P304
P356
10.1097/00129039-200112000-00007
P577
2001-12-01T00:00:00Z